Experienced in Trichohepatoenteric Syndrome

Dr. Daniel A. Norman

Gastroenterology
2170 South Ave, 
South Lake Tahoe, CA 
Experienced in Trichohepatoenteric Syndrome
2170 South Ave, 
South Lake Tahoe, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Daniel Norman is a Gastroenterologist in South Lake Tahoe, California. Dr. Norman is rated as an Experienced provider by MediFind in the treatment of Trichohepatoenteric Syndrome. His top areas of expertise are Esophagitis, Barrett Esophagus, Familial Adenomatous Polyposis, Colonoscopy, and Endoscopy.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

2170 South Ave, South Lake Tahoe, CA 96150

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
Enrollment Status: Terminated
Publish Date: October 29, 2024
Intervention Type: Drug
Study Drug: TAK-994
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
Enrollment Status: Terminated
Publish Date: December 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
Enrollment Status: Active_not_recruiting
Publish Date: September 14, 2023
Intervention Type: Drug
Study Drug: Pitolisant
Study Phase: Phase 2
Open-Label 4-Period Dose-Escalation Safety and Efficacy Study of AD313 in Participants With Obstructive Sleep Apnea
Open-Label 4-Period Dose-Escalation Safety and Efficacy Study of AD313 in Participants With Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: April 07, 2023
Intervention Type: Drug
Study Drugs: Atomoxetine, AD313
Study Phase: Phase 1/Phase 2
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: January 17, 2023
Intervention Type: Drug
Study Phase: Phase 2
Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: December 12, 2022
Intervention Type: Drug
Study Drugs: AD109, AD504, Atomoxetine Hydrochloride
Study Phase: Phase 2
Evaluation of Novel Proprietary Biometric as an Aid in the Screening and Diagnosis of Sleep Breathing Disorders
Evaluation of Novel Proprietary Biometric as an Aid in the Screening and Diagnosis of Sleep Breathing Disorders
Enrollment Status: Terminated
Publish Date: February 26, 2019
View 8 Less Clinical Trials

3 Total Publications

Effect of viloxazine and trazodone in obstructive sleep apnoea: a randomised, placebo-controlled, cross-over study.
Effect of viloxazine and trazodone in obstructive sleep apnoea: a randomised, placebo-controlled, cross-over study.
Journal: Thorax
Published: September 27, 2024
Similar Doctors
Advanced in Trichohepatoenteric Syndrome
Dr. Jason Collins
Gastroenterology
Advanced in Trichohepatoenteric Syndrome
Dr. Jason Collins
Gastroenterology

Collins Carson City Gastroenterology, Ltd

1385 Vista Ln, 
Carson City, NV 
 (22.9 miles away)
775-884-4567
Languages Spoken:
English
See accepted insurances

Jason Collins is a Gastroenterologist in Carson City, Nevada. Dr. Collins is rated as a Distinguished provider by MediFind in the treatment of Trichohepatoenteric Syndrome. His top areas of expertise are Familial Adenomatous Polyposis, Portal Hypertension, Childhood Volvulus, Endoscopy, and Gastrectomy.

Advanced in Trichohepatoenteric Syndrome
Dr. Michael Solinger
Gastroenterology
Advanced in Trichohepatoenteric Syndrome
Dr. Michael Solinger
Gastroenterology
1385 Vista Ln, 
Carson City, NV 
 (22.9 miles away)
775-388-4456
Languages Spoken:
English
See accepted insurances

Michael Solinger is a Gastroenterologist in Carson City, Nevada. Dr. Solinger is rated as a Distinguished provider by MediFind in the treatment of Trichohepatoenteric Syndrome. His top areas of expertise are Colitis, Visceromegaly, Barrett Esophagus, Endoscopy, and Colonoscopy.

Advanced in Trichohepatoenteric Syndrome
Dr. Kevin Hill
Gastroenterology
Advanced in Trichohepatoenteric Syndrome
Dr. Kevin Hill
Gastroenterology

Dignity Health Medical Foundation

300 Sierra College Dr, Suite 220, 
Grass Valley, CA 
 (60.9 miles away)
530-273-3377
Languages Spoken:
English
See accepted insurances

Kevin Hill is a Gastroenterologist in Grass Valley, California. Dr. Hill is rated as an Advanced provider by MediFind in the treatment of Trichohepatoenteric Syndrome. His top areas of expertise are Gardner Syndrome, Turcot Syndrome, Gastritis, Gastrectomy, and Gastrostomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Norman's expertise for a condition
ConditionClose
        View All 18 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile